Company news
Instil Bio, Inc. news in 2026
Instil Bio, Inc.'s news releases, calls and decks from 2026, newest first.
Instil Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 13, 2026
Instil Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 15, 2026
Instil Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
March 26, 2026
Instil Bio’s Subsidiary Discontinues Clinical Development of AXN-2510 and Terminates License and Collaboration Agreement with ImmuneOnco
January 6, 2026